FDA Approved: NUZYRA — Supplemental Application (Paratek Pharmaceuticals, Inc.)

View source ↗

Summary

FDA notice about a supplemental application for Nuzyra (omadacycline) from Paratek Pharmaceuticals to request changes to the product label; the submission statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Skin and Skin Structure Infections
• Community-acquired Bacterial Pneumonia

Drugs mentioned

• Nuzyra (Omadacycline)

Snippet

SUPPL AP for NUZYRA (OMADACYCLINE)